The U.S. Food and Drug Administration (FDA) recently announced the approval of its first drug to treat Fibromyalgia. Fibromyalgia & Fatigue Centers, Inc., a national network of medical centers that specialize in treating patients with Fibromyalgia and Chronic Fatigue Syndrome, welcomes this announcement as one more step towards increasing recognition and validation by U.S. government health officials and others in the healthcare community of the seriousness of Fibromyalgia.
With the number of Americans suffering from this debilitating condition having risen in recent years to nearly 12 million, Fibromyalgia represents a population of nearly 4%, and can no longer be...
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry